CIBC Private Wealth Group LLC Sells 1,351 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

CIBC Private Wealth Group LLC lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 92,539 shares of the biotechnology company’s stock after selling 1,351 shares during the period. CIBC Private Wealth Group LLC owned 0.12% of Axon Enterprise worth $53,426,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in AXON. The Manufacturers Life Insurance Company increased its position in Axon Enterprise by 0.6% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock worth $17,440,000 after buying an additional 276 shares during the period. Quantbot Technologies LP bought a new position in Axon Enterprise during the third quarter worth about $84,000. Townsquare Capital LLC acquired a new stake in Axon Enterprise in the 3rd quarter worth about $261,000. Public Sector Pension Investment Board grew its position in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after purchasing an additional 500 shares in the last quarter. Finally, Martingale Asset Management L P acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $252,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $534.95 on Monday. The firm has a market capitalization of $40.99 billion, a price-to-earnings ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The business’s 50-day moving average price is $589.62 and its 200-day moving average price is $550.61. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.